HealthEquity Profit Margin vs Operating Income Analysis

HQY Stock  USD 81.19  0.30  0.37%   
HealthEquity financial indicator trend analysis is much more than just examining HealthEquity latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether HealthEquity is a good investment. Please check the relationship between HealthEquity Net Profit Margin and its Operating Income accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HealthEquity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.
For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.

Net Profit Margin vs Operating Income

Profit Margin vs Operating Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of HealthEquity Profit Margin account and Operating Income. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between HealthEquity's Profit Margin and Operating Income is -0.23. Overlapping area represents the amount of variation of Profit Margin that can explain the historical movement of Operating Income in the same time period over historical financial statements of HealthEquity, assuming nothing else is changed. The correlation between historical values of HealthEquity's Profit Margin and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Profit Margin of HealthEquity are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Profit Margin i.e., HealthEquity's Profit Margin and Operating Income go up and down completely randomly.

Correlation Coefficient

-0.23
Relationship DirectionNegative 
Relationship StrengthInsignificant

Net Profit Margin

The percentage of revenue left after all expenses have been deducted from sales. The measure is calculated by dividing net profit by revenue.

Operating Income

Operating Income is the amount of profit realized from HealthEquity operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of HealthEquity is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.
Most indicators from HealthEquity's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into HealthEquity current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HealthEquity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.
For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.At this time, HealthEquity's Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to rise to about 20.3 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.08 in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit423.7M490.1M529.9M556.4M
Total Revenue756.6M861.7M999.6M1.0B

HealthEquity fundamental ratios Correlations

0.910.890.980.970.670.690.610.990.760.91-0.760.950.910.930.760.920.850.840.831.00.670.940.750.920.97
0.910.990.850.950.610.720.760.880.740.85-0.750.920.980.970.770.910.960.90.90.920.680.940.770.970.84
0.890.990.810.940.550.660.780.850.70.82-0.720.90.970.940.720.90.980.920.870.890.620.90.720.960.79
0.980.850.810.90.720.720.540.980.770.9-0.730.910.830.890.770.910.740.730.80.970.710.930.760.831.0
0.970.950.940.90.570.620.630.950.680.87-0.740.960.960.930.70.90.940.920.840.970.590.90.70.960.88
0.670.610.550.720.570.430.610.660.590.57-0.480.50.60.740.550.590.480.550.510.690.40.720.560.60.73
0.690.720.660.720.620.430.490.640.770.84-0.650.680.620.650.870.690.580.410.90.640.990.760.870.610.7
0.610.760.780.540.630.610.490.530.580.62-0.60.510.740.770.570.580.770.710.690.620.440.690.570.720.53
0.990.880.850.980.950.660.640.530.720.88-0.740.940.890.910.710.910.810.830.780.990.610.920.70.90.97
0.760.740.70.770.680.590.770.580.720.75-0.560.680.70.760.870.70.640.570.780.730.780.810.870.70.76
0.910.850.820.90.870.570.840.620.880.75-0.840.870.820.830.780.830.780.690.930.890.820.870.770.820.88
-0.76-0.75-0.72-0.73-0.74-0.48-0.65-0.6-0.74-0.56-0.84-0.74-0.72-0.72-0.44-0.7-0.69-0.63-0.81-0.75-0.6-0.73-0.44-0.72-0.72
0.950.920.90.910.960.50.680.510.940.680.87-0.740.880.860.690.970.860.80.810.940.660.870.680.880.9
0.910.980.970.830.960.60.620.740.890.70.82-0.720.880.970.710.840.960.970.850.920.580.930.711.00.81
0.930.970.940.890.930.740.650.770.910.760.83-0.720.860.970.750.870.910.920.840.950.610.980.750.970.88
0.760.770.720.770.70.550.870.570.710.870.78-0.440.690.710.750.710.670.560.840.730.890.821.00.710.76
0.920.910.90.910.90.590.690.580.910.70.83-0.70.970.840.870.710.830.750.780.910.660.860.70.840.9
0.850.960.980.740.940.480.580.770.810.640.78-0.690.860.960.910.670.830.940.840.860.540.840.670.960.72
0.840.90.920.730.920.550.410.710.830.570.69-0.630.80.970.920.560.750.940.70.870.360.840.560.970.72
0.830.90.870.80.840.510.90.690.780.780.93-0.810.810.850.840.840.780.840.70.810.880.870.840.840.77
1.00.920.890.970.970.690.640.620.990.730.89-0.750.940.920.950.730.910.860.870.810.610.940.720.930.96
0.670.680.620.710.590.40.990.440.610.780.82-0.60.660.580.610.890.660.540.360.880.610.730.890.570.68
0.940.940.90.930.90.720.760.690.920.810.87-0.730.870.930.980.820.860.840.840.870.940.730.820.940.92
0.750.770.720.760.70.560.870.570.70.870.77-0.440.680.710.751.00.70.670.560.840.720.890.820.710.75
0.920.970.960.830.960.60.610.720.90.70.82-0.720.881.00.970.710.840.960.970.840.930.570.940.710.82
0.970.840.791.00.880.730.70.530.970.760.88-0.720.90.810.880.760.90.720.720.770.960.680.920.750.82
Click cells to compare fundamentals

HealthEquity Account Relationship Matchups

HealthEquity fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets2.6B2.7B3.1B3.1B3.2B3.4B
Other Current Liab96.7M126.2M104.7M89.5M95.6M54.8M
Total Current Liabilities152.1M204.3M153.2M131.1M117.1M79.0M
Total Stockholder Equity1.0B1.4B1.9B1.9B2.0B2.1B
Other Liab133.1M128.5M114.0M95.4M109.7M115.2M
Accounts Payable4.0M1.6M27.5M13.9M12.0M6.9M
Cash191.7M328.8M225.4M254.3M404.0M212.6M
Other Assets35.1M37.4M49.8M52.2M1.00.95
Good Will1.3B1.3B1.6B1.6B1.9B2.0B
Common Stock Shares Outstanding68.5M75.7M83.1M84.4M87.0M68.4M
Other Current Assets33.8M58.6M38.5M31.8M48.6M51.0M
Total Liab1.5B1.3B1.3B1.2B1.2B609.8M
Intangible Assets783.3M767.0M973.1M936.4M835.9M428.2M
Property Plant Equipment33.5M118.6M87.0M69.3M79.7M83.7M
Property Plant And Equipment Net116.7M118.6M87.0M69.3M54.4M47.5M
Net Debt1.1B746.2M782.8M740.2M529.2M299.8M
Retained Earnings211.5M220.3M176.1M149.9M205.6M121.8M
Non Current Assets Total2.3B2.2B2.8B2.7B2.7B2.8B
Cash And Short Term Investments191.7M328.8M225.4M254.3M404.0M243.5M
Net Receivables70.5M72.8M87.4M96.8M104.9M52.6M
Liabilities And Stockholders Equity2.6B2.7B3.1B3.1B3.2B1.6B
Non Current Liabilities Total1.4B1.1B1.1B1.1B1.1B578.7M
Other Stockholder Equity818.8M1.2B1.7B1.7B1.8B1.9B
Property Plant And Equipment Gross116.7M118.6M87.0M69.3M95.4M51.6M
Total Current Assets296.0M460.2M351.3M382.9M557.4M320.0M
Net Tangible Assets(1.1B)(715.1M)(766.4M)(688.9M)(620.0M)(589.0M)
Non Currrent Assets Other35.1M37.4M49.8M52.2M(768.1M)(729.7M)
Retained Earnings Total Equity85.3M171.9M211.5M220.3M253.4M266.1M
Capital Surpluse261.2M305.2M818.8M1.2B1.3B1.4B
Non Current Liabilities Other1.4B8.8M14.2M12.7M19.3M18.3M
Net Invested Capital2.3B2.4B2.8B2.8B2.9B2.2B
Net Working Capital145.4M255.5M198.2M251.8M440.3M298.8M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether HealthEquity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of HealthEquity's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Healthequity Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Healthequity Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HealthEquity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.
For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for HealthEquity Stock analysis

When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Is HealthEquity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HealthEquity. If investors know HealthEquity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HealthEquity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.96)
Earnings Share
0.64
Revenue Per Share
11.682
Quarterly Revenue Growth
0.122
Return On Assets
0.0256
The market value of HealthEquity is measured differently than its book value, which is the value of HealthEquity that is recorded on the company's balance sheet. Investors also form their own opinion of HealthEquity's value that differs from its market value or its book value, called intrinsic value, which is HealthEquity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HealthEquity's market value can be influenced by many factors that don't directly affect HealthEquity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HealthEquity's value and its price as these two are different measures arrived at by different means. Investors typically determine if HealthEquity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HealthEquity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.